Skip to main content
INBX logo

INBX · Inhibrx Biosciences, Inc. · Held by Funds

Track INBX — free
$95.85 +6.06 (+6.75%)
Market Cap
$1.32B
Shares
14.72M
Volume · Oct 20 41.67K Avg daily vol (3M) 276.09K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of INBX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 13.01% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.24% 329,334
Index ETFs 10.77% 1,585,284
Active ETFs 0.27% 39,636
Active funds 3.68% 541,887
Unclassified 0.00% 0
All registered funds 16.96% 2,496,141
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding INBX

153 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 153 positions
Key facts CIK 2007919 CUSIP 45720N103 13F (30d) 12 filings 12 filers Visit website Investor relations